Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Yah, I meant .0004 obviously. LOL
I bought another 3 million at .004 in the last two days.
If the dividend has been figured in the buyout offer of $0.55 (if buyout ever happens) then your dilution suggestion means nothing. It will be $0.55 for every share regardless.
Thanks skier for your time and sharing this with all of us.
This company is a joke with Moody and Big Apple behind the wheel, anyone buying this stock or dealing with EVSY is apparently not aware of the current BOD's track record.
Moody and Big Apple are trying to pull the wool over everyones eyes. Ask yourself about the pending acquisitions, how are they going to purchase any companies. Only way is to pay them in EVSY shares. Yes, we will buy back 5 million and then give away another 100 million to acquire a company.
What good does that do? How would that improve the price of the company? Since it is so undervalued. What a joke, no way is this stock undervalued, overvalued more like it. Frank is just pulling the same stuff, I bet you could go to a HISC PR, and see that it is almost identical to this BS PR.
No cash to work with, no revenue, and they are going to buy back 5 million shares. During that time we will sell 7 million shares to pay for the 5 million share buyback.
If there is a buyout offer, you are wrong in thinking that they can keep issuing themselves more shares. Otherwise that .55 offer would drop with every share issued.
The point is, it wasn't there, and it still isn't there. But every calculation he used those numbers like it was fact. That is unsubstantiated BS, in my opinion.
Yah, his 8-10 billion shares outstanding was right on. That was without a doubt substantiated by the 1st Quarter Report.
Company News from Website
MMC joins the band of elite users of the DCM System
eFotoXpress is proud to announce the successful installation of their DCM ROBOT at Makati Medical Center (MMC) in the Philippines. MMC is the first hospital in the country to adopt a fully digital picture archiving sharing solution of the DCM ROBOT. It has joined the band of elite users of the DCM ROBOT. MMC is now able to access images remotely anywhere in the world and is the first hospital to adopt a fully automated optical archiving solution.
The DCM ROBOT will also allow MMC to enter the world in Tele-Radiology. Outsourcing image reading is the growing trend in Radiology.
Edward Tan, CEO of eFotoXpress said, “The stage is set for MMC to start receiving images from anywhere in the world for pre-reading and full diagnostic reading.”
Yah, I seen the shareholder meeting mentioned there, I just hadn't seen it mentioned anywhere before. Didn't know he had intended on having one in July until that shareholder email.
That was the first that I had heard of in regards to a shareholder meeting. We have three months, I think that if there are a bunch of irons in the fire come September 30, that he will list regardless of revenue at that time. The main reason being that if they are prepared to do it at that time, then they probably should go ahead, especially, if they forsee a revenue stream in the near future. I wouldn't mind a lower opening price if it gives the opportunity to buy some more shares, as long as we are able to sustain or build on that price with continuing revenues and maintain the price required to list to the higher exchange. The other thing is, the sooner we list, the sooner we can move to a real exchange like the AMEX or NASDAQ. Where we don't have to worry so much about the stock manipulation that occurs in the OTC and pink lands. I think Edward fully anticipates to have the revenue needed by that time, I think that is why he would postpone a scheduled shareholders meeting, because he want to do the most that he can to get that revenue for his company and the shareholders.
No, it is going to depend largely on how much revenue they have generated at the time of listing. You can look back through some of my postings to get a general idea depending on the revenue, but I think financials are suppose to come out prior to listing. A good post to refer to may be Edward's initial shareholder email about the Listing Information in Post#62
It's good to know we finally got our foot in the door in the US retail market. I like what I see so far from this company. Let's hope they can stick to their guns and produce. I have a lot of confidence in Edward right now. He is striving for success.
News Update: Overseas Business/Local Business
7/2/2007
Dear Fellow Stock Holders:
Originally I was going to call for a stock holders meeting in July but I have to change plans and perhaps call for one immediately after I return from another overseas trip. I am set to leave again for the Orient. I have several pending sales. The first one is in Singapore. I have received inquiries from two different hospitals. The next order is from Thailand. This is a group of 8 private hospitals. The third one is from another private hospital in the Philippines. I will give you my report when I return.
As for the United States, I have made some progress. I have concluded an agreement with a marketing company who will take our product into the Medical Retail market. The group has people who are very connected into the medical retail market. One of them come from a very well-known name and the other has 20 years experience selling to the medical industry. I can only hope and pray for the best and I can only wish them all the very best of luck. Only limited exclusivity has been given and until they produce results we will continue to look for more distributors.
Thank you.
With Best Regards
Edward Tan
CEO
Good find Mind,
Effort always appreciated
LOL, that's all I got to say or express and I can't even see stock's posts.
A bit of speculation maybe, but figuring number of employees and the fact that all of the cost of manufacturing the product should go in the cost of goods sold line item. I can generate a pretty good idea of where we should be profitable at. And I believe that is it. Not total speculation, only partial.
This is some additional information from EFOTOEXPRESS website.
I think this is an interesting point in regards to potential annual revenue after intial placement of equipment with customer.
30 Days Trial Program:
We will setup and integrate the DCM System(Advanced PACS) at no cost to you. At the end of the trial, you may request us to take the equipments back(at our cost). You can also decide to purchase the system outright or license its use. Licensing fee is $15,000/year (unlimited clients/transactions/backups). A one time setup fee will apply.
Leonardo, there is a market, and that is quite obvious to everyone except for you. However, we have yet to obtain our portion of the market. And when/if we do, we need to be producing this equipment for a profit by then. Every little bit to reduce costs helps, regardless of how you see it.
I disagree, right now they are in Business 101, not marketing 101. What does it matter if you can market a product and sell more of that product, but lose money everytime you sell a product. We need to work toward profit with every sell of the CT. I have said it before, and I will say it again, we should be profitable if are selling 450 or more CT's per month. Right now we are no where close to being profitable and that is where we are most likely at in the terms of the number of CT's sold per month.
I personally don't think they will pass any of these savings onto the consumer. Just not very likely in this case. We are trying to make a profit for the first time yet.
Per Edward, the 1.25 million in sales was just for the DCM Robot so far.
I personally liked this PR, and this is coming from an unhappy camper. But as you all know, I have been pounding HISC over the last week or two about needing to reduce costs or increase sales price, because I think we should be breaking even with current sales. So, I think this post was acknowledging my concerns in regards to cost/net profit issues per CT. Keep up the efforts Fred, but more needs to be done in regards to SG&A costs. I think the current 41% markup on the CT is reasonable, so if we can improve to get this closer to 50% would be nice. But then we should be able to get about 15% to 20% or so after SG&A costs and this then should get better or worse from there depending on the number of sales.
Spence and skier, what did you think about my 2nd quarter projections. You have any disagreements with what I posted.
No not yet. Re-listing to occur by September 30, 2007.
49,000,000 outstanding with 100,000,000 authorized. Check out the board info page for more information.
EFOT building momentum for a listing to be obtained prior to September 30, 2007. Visit EFOT board and read recent news from CEO to shareholders. Right now, mention of $150 million plus in revenues overseas for our medical equipment. Mark the board and follow along while updates from CEO to shareholders continue until listing date.
To be honest, I may be looking at buying some more once 2nd quarter financials come out, but I am looking for some specific signs on the financials.
So if I buy after 2nd quarter financials then everyone should be buying, because I am in holding pattern until I see some specific things on the financials.
No point in me selling either. Too much to lose at this point. Just hoping HISC reads this board and sees the frustration that they are causing for us shareholders, and how they are losing our support. Because who do they think has been buying the shares to keep them in business.
I had to smile when I read the opening paragraph about our success in the Philipines. I think this is the most exciting paragraph in the email.
News 6/21/2007: Shareholder email: UPDATE
Dear Fellow Stock Holders:
I have just returned from what I would call a very successful overseas trip only to say that I will be leaving again in two weeks. I will categorize my achievements as follows:
PHILIIPPINES
We continued to make substantial progress selling DCM ROBOT in the Philippines. Our demo at Makati Medcial Center (MMC) has turned to a sale and we got paid. It had earned creditability with numerous prospective customers calling at MMC to see and even talked to the Head Radiologist. This has further led to two more sales. We now have a total of three in the Philippines and one at demo stage. Philippines is undergoing major changes in their medical sector – from analog to digital. We could not have been here at a better time. Our timing was just perfect. Fortunately because our pricing structure we were able to walk over all our competitors in the Philippines. In the next two weeks we will commence our first pilot test at one of the 88 Government Hospitals. Thirty days after evaluation we will proceed to enter an agreement to interface all 88 hospitals with a PACS system. The project is estimated at $15 million. Our experience in the Philippines has further strengthened our confidence in the product. In a very short time we will commence our first tele-radiology setup at MMC. MMC will become the first hospital to accept images from the US for pre-reading. More and more hospitals in the US are seeking outsourcing reading from overseas because of cost issues. Meanwhile MMC will be proceeding to get accreditation so that they will be allowed to attest readings at all levels. The pipe for tele-radiology has already been established. Our pricing structure actually has shut out competitors like Toshiba, Siemens, GE and Philips in the middle market. No hospital in the Philippines has adopted a full PACS system using the Siemens or GE systems. This may be our only opportunity to become a major player in the Philippines. We will continue to dominate this market here.
HONG KONG
Hong Kong continues to show interest in our product although we face stiff competition from major suppliers like Siemens and GE. The market here is relatively small compared to Philippines. We have an agent in Hong Kong and they have been working very hard to get our name into the market. On my last trip we visited the Children’s Hospital and Queen Mary’s hospital. We have decided to allow one unit to be on demo at one of the recognized hospital. We have decided not to participate in Government Hospitals as the tender process will take too long.
CHINA
China continues to dominate the world as the largest market in everything. Our agent is now proceeding with registration of the product. China is very strict about product registration. This should not take too long. In the mean time demo is allowed pending the registration process. Our agent has identified a hospital in Shanghai where we will begin a demo process. This is being done right now. Within the next 30 days we will commence a FULL SCALE demo. The purpose once again is to earn creditability. The demo should be completed within 30 days whereby we will proceed to enter into an agreement to proceed with a pilot test at 100 sites. This project is estimated at another $15 million. Within six months after its completion we will start implementing a massive project within China. Our DCM ROBOT has been localized in Chinese. If and when completely implemented we project revenue from China to be about $150 million. However it will take over a period of 2 years. Once again our agents and their connections in China have made this possible.
USA
We have not forgotten the world’s most vibrant and inhospitable market in radiology. While the market is much bigger than anywhere in the world except China, we tend to face very stiff competition. However we are not going to remain unattentative. We are in the process of entering an agreement with a consortium who has put up a marketing plan to sell our product in the USA. Within the next two weeks we will hire a National Sales Manager to take care of the program and to ensure that we also can become a major player in the US. I don’t see why we are unable to do well in the US when we have succeeded elsewhere.
If sales in the US are not forthcoming then we need to go elsewhere to generate revenue. Many times great products become household name overseas before it really gets back into the US.
Our total sales so far reached $1.25 million. We project another $8 million for the next quarter.
Thanks for reading.
With Warmest Regards
Edward Tan, CEO
I think everyone should bail, and see if this company finally responds. So far response has been minimal. No buybacks, no retirement, just selling more shares.
I calculated a $151 profit per CT at 1st quarter on 639 units. I think we will have 1300 units at end of 2nd quarter. A bit over double of 1st quarter sales. 1300 x $151 = $196,300 gross profit and an additional $36,000 of gross profit from other areas, accessories, residuals, etc.
This for a total gross profit before SG&A expenses of $232,300. Assuming $407,700 in SG&A with no decreases in SG&A and no increases (we better not have increases) that would leave us at a net loss of nearly $175,000.
I think this is a pretty solid calculation and estimate in my opinion.
Like I said in the same post about cost/unit, currently we need 2400 units to break-even, obtainable YES, should we need that many to break even, NO. $407,700 SG&A for this currently small company is a joke. I mean how many employees do we have? 20. If so you and I know salary and benefit expense make up nearly 80% or more of a company's expenses when we have already broken out cost of goods sold. So that would be $65,000/year for each employee (assuming 20 employees, I don't think we have that many). A little much for a startup company. Are we just selling CTs and stock so that these guys can have a paycheck. It's not like the expenses for maintaining our offices should be much as someone has shown with the pictures of the office.
I have given this company plenty of opportunity to improve the PPS. Not being at .02 at this point, I can understand, but to be back here at .0005 is absolutely ridiculous. In my opinion, this company cannot obtain the sales they need unless they cut more costs or increase prices. What their doing know just isn't cutting it. Selling 650 CT's in a quarter and they still can't turn a profit. I think we should be even at that point. I'm on the losing end here, and losing hope.
Yep, ignore it is.
Had a typo in my post.
Assuming that we would have a larger profit margin as Selling and General Expenses would not increase at the same rate as revenue.
$175,000,000 x 30% profit margin = $52,500,000
Outstanding shares = 50,000,000
EPS: $5,000,000/50,000,000 = 1.05/share
Assuming a PE ratio of 25 (10-40 market range)
1.05 * 25 = $26.25
SHOULD BE
Assuming that we would have a larger profit margin as Selling and General Expenses would not increase at the same rate as revenue.
$175,000,000 x 30% profit margin = $52,500,000
Outstanding shares = 50,000,000
EPS: $52,500,000/50,000,000 = 1.05/share
Assuming a PE ratio of 25 (10-40 market range)
1.05 * 25 = $26.25